当前位置：首页>产品中心>单抗/多抗>Anti-Human Endoglin/CD105 Reference Antibody|抗人Endoglin/CD105参考抗体(靶标：人CD105/Endoglin)
Anti-Human Endoglin/CD105 Reference Antibody|抗人Endoglin/CD105参考抗体(靶标：人CD105/Endoglin)
- 货号：RB9THB604016
- 价格：面议
- 点击：593
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Chimeric |
| 克隆性 | Monoclonal |
| 抗体亚型 | IgG1-kappa |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 浓度 | 1mg/ml |
| 内毒素水平 | Please contact the lab for this information. |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | CD105, END, Endoglin, ENG |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 表达系统 | Mammalian Cells |
| 登录号 | P17813 |
| 背景信息 | Carotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions. • Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease., PMID:36614087 • Microvascular endoglin (CD105) expression correlates with tissue markers for atherosclerotic plaque vulnerability in an ageing population with multivessel coronary artery disease., PMID:22463585 • Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining., PMID:15272276 • Antibody phage display technologies with special reference to angiogenesis., PMID:15746176 • Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells., PMID:23917399 • Generation of a Soluble Form of Human Endoglin Fused to Green Fluorescent Protein., PMID:34681942 • Synovial biomarkers in psoriatic arthritis., PMID:22751595 • Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide., PMID:11691802 • A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma., PMID:27328856 • Elabela gene therapy promotes angiogenesis after myocardial infarction., PMID:34291565 |
| 别名 | TRC-105, c-SN6j, 1268714-50-6 |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
相关产品:
